| 查看: 562 | 回复: 0 | |||
[交流]
美国休斯顿卫理公会癌症中心诚招博后
|
|
One postdoctoral position in the field of the tumor microenvironment is available in Dr. Jing Yang’s lab at Houston Methodist Cancer Center, Houston Methodist Research Institute. The fellow is being recruited for projects aimed at identifying biomarkers for therapeutic targets in multiple myeloma. The overarching goal of Dr. Yang’s translational research program is to study the mechanism underlying the pathogenesis of multiple myeloma. The lab currently focusing on the interaction of tumor cells with adipocytes, the association of obesity and cancer, and the role of bone marrow microenvironment in chemotherapy, immunotherapy, and bone metastasis. These studies aim to provide novel and potential therapeutic targets and tools for the treatment of myeloma patients. Please refer to our recent publications for more information (Science Translational Medicine 8(353):353ra113, 2016. PMID: 275590962016; Science Translational Medicine 11(494), 2019. PMID: 31142679; Science Signaling. 2020 26; 13(633); Cell Metabolism Vol.33, Iss.1 2021). We seek a highly motivated and independent candidate who has a recent Ph.D. and/or M.D. degree with less than two years of postdoctoral experience in one or more of the following areas: molecular/cellular biology, metabolism, immunology, tumor metastasis, and bone disease research. A candidate with a solid molecular biology background is preferred. The pay scale follows the NIH guidelines. A track record of excellent first author publication during Ph.D. training is essential. Applications, including curriculum vitae, the contact information of three references, and a summary of accomplishments should be sent to Dr. Jing Yang: jingyang318@gmail.com. Jing Yang, PhD Associate Professor Houston Methodist Cancer Center Houston Methodist Research Institute 6550 Fannin St., SM8-023 Houston, TX 77030 jyang2@houstonmethodist.org |
回复此楼» 猜你喜欢
东华理工大学化材专业26届硕士博士申请
已经有5人回复
-
本人考085602 化学工程 专硕
已经有5人回复
-
伙伴们，祝我生日快乐吧
已经有22人回复
-
调剂
已经有7人回复
-
289求调剂
已经有5人回复
-
一志愿武理314求调剂
已经有6人回复
-
欢迎申博同学联系
已经有5人回复
-
288求调剂
已经有4人回复
-
国自科面上基金字体
已经有4人回复
-
梁成伟老师课题组欢迎你的加入
已经有6人回复
